Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study

Autor: Soto Parra, H. *, Cavina, R., Latteri, F., Sala, A., Dambrosio, M., Antonelli, G., Morenghi, E., Alloisio, M., Ravasi, G., Santoro, A.
Zdroj: In Annals of Oncology July 2002 13(7):1080-1086
Databáze: ScienceDirect